ProKidney Corp. (PROK)
NASDAQ: PROK · Real-Time Price · USD
4.540
-0.640 (-12.36%)
At close: Jul 11, 2025, 4:00 PM
4.550
+0.010 (0.22%)
After-hours: Jul 11, 2025, 7:59 PM EDT
ProKidney Employees
ProKidney had 204 employees as of December 31, 2024. The number of employees increased by 41 or 25.15% compared to the previous year.
Employees
204
Change (1Y)
41
Growth (1Y)
25.15%
Revenue / Employee
$1,500
Profits / Employee
-$335,431
Market Cap
1.33B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 204 | 41 | 25.15% |
| Dec 31, 2023 | 163 | 76 | 87.36% |
| Dec 31, 2022 | 87 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
PROK News
- 2 days ago - ProKidney: What's Happening With PROK Stock? - Forbes
- 2 days ago - ProKidney to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference - GlobeNewsWire
- 3 days ago - ProKidney's stock rockets on ‘intriguing' news, but analyst doesn't recommend buying - Market Watch
- 3 days ago - Gold Falls 1%; ProKidney Shares Spike Higher - Benzinga
- 3 days ago - Why Is Penny Stock ProKidney Trading Higher On Tuesday? - Benzinga
- 3 days ago - ProKidney Reports Statistically and Clinically Significant Topline Results for the Phase 2 REGEN-007 Trial Evaluating Rilparencel in Patients with Chronic Kidney Disease and Diabetes - GlobeNewsWire
- 10 days ago - ProKidney Corp. Completes Domestication from the Cayman Islands to Delaware - GlobeNewsWire
- 2 months ago - ProKidney Reports First Quarter 2025 Financial Results and Business Highlights - GlobeNewsWire